Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl

FDA Drug Profile — ALTUVIIIO

Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl is listed in the FDA National Drug Code directory with 12 NDC codes, marketed under brand name including ALTUVIIIO. Available dosage form: kit.

Drug details

Generic Name
Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl
Brand Names
ALTUVIIIO
Application Number
BLA125771
Sponsor
Bioverativ Therapeutics Inc.
NDC Codes
12
Dosage Forms
KIT

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.